These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24018496)

  • 1. Treatment of polycystic liver disease: a hypothesis, patient characteristics, short and long-term results.
    Long-Xian Z; Ai-Wu L; Hua-Dong Q; Jun C; Hui-Jie J; Hong-Bo J
    Ann Hepatol; 2013; 12(5):782-90. PubMed ID: 24018496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts.
    van Keimpema L; de Koning DB; Strijk SP; Drenth JP
    Dig Dis Sci; 2008 Aug; 53(8):2251-7. PubMed ID: 18299984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease.
    Erdogan D; van Delden OM; Rauws EA; Busch OR; Lameris JS; Gouma DJ; van Gulik TM
    World J Gastroenterol; 2007 Jun; 13(22):3095-100. PubMed ID: 17589926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
    Neijenhuis MK; Wijnands TFM; Kievit W; Ronot M; Gevers TJG; Drenth JPH
    Eur Radiol; 2019 Jun; 29(6):3062-3068. PubMed ID: 30542749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease.
    Takita M; Iwanishi M; Minami T; Kono M; Chishina H; Arizumi T; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Naoshi N; Kudo M
    Dig Dis; 2016; 34(6):654-658. PubMed ID: 27750233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial.
    Wijnands TF; Gevers TJ; Kool LJ; Drenth JP
    Trials; 2015 Mar; 16():82. PubMed ID: 25873132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous aspiration and alcohol sclerotherapy for symptomatic hepatic cysts. An alternative to surgical intervention.
    Kairaluoma MI; Leinonen A; Ståhlberg M; Päivänsalo M; Kiviniemi H; Siniluoto T
    Ann Surg; 1989 Aug; 210(2):208-15. PubMed ID: 2667475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic Review.
    Wijnands TF; Görtjes AP; Gevers TJ; Jenniskens SF; Kool LJ; Potthoff A; Ronot M; Drenth JP
    AJR Am J Roentgenol; 2017 Jan; 208(1):201-207. PubMed ID: 27824501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic cyst infection following aspiration sclerotherapy: a case series.
    Wijnands TF; Lantinga MA; Drenth JP
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):441-4. PubMed ID: 25532005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic fenestration in combination with ethanol sclerotherapy prevents a recurrence of symptomatic giant liver cyst.
    Tanaka S; Watanabe M; Akagi S; Sato S; Niigaki M; Nogami C; Hamamoto S; Moriyama N; Kinoshita Y
    Surg Laparosc Endosc; 1998 Dec; 8(6):453-6. PubMed ID: 9864114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of polycystic liver disease.
    van Keimpema L; Höckerstedt K
    Br J Surg; 2009 Dec; 96(12):1379-80. PubMed ID: 19918853
    [No Abstract]   [Full Text] [Related]  

  • 12. Polycystic liver disease: a clinical review.
    Chandok N
    Ann Hepatol; 2012; 11(6):819-26. PubMed ID: 23109444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol sclerotherapy of simple parenchymal liver cysts.
    McCullough KM
    Australas Radiol; 1993 May; 37(2):177-81. PubMed ID: 8512508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of symptomatic polycystic liver disease: laparoscopy adjuvant with alcohol sclerotherapy.
    Jeng KS; Yang FS; Kao CR; Huang SH
    J Gastroenterol Hepatol; 1995; 10(3):359-62. PubMed ID: 7548819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of sclerotherapy in treatment of non-parasitic hepatic cysts].
    Iareshko VG; Otarashvili KN
    Klin Khir; 2009; (7-8):131-2. PubMed ID: 20218399
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous treatment of hepatic cysts by aspiration and sclerotherapy.
    Simonetti G; Profili S; Sergiacomi GL; Meloni GB; Orlacchio A
    Cardiovasc Intervent Radiol; 1993; 16(2):81-4. PubMed ID: 8485748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complicated polycystic liver disease with intracystic hemorrhage and obstructive jaundice].
    Rosenfeld L; Abergel A; Bonny C; Poincloux L; Gayard P; Garcier JM; Scribe-Outtas M; Bommelaer G
    Gastroenterol Clin Biol; 2001; 25(8-9):818-22. PubMed ID: 11598544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simple cysts of the liver].
    Catania G; Cardí F; Petralia A; Salanitri F; Catalano F; Marzullo E
    Minerva Chir; 1997 Jun; 52(6):823-30. PubMed ID: 9324669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic cyst excision and partial hepatectomy for Todani type IV-A cysts.
    Xia HT; Dong JH; Yang T; Zeng JP; Liang B
    Dig Liver Dis; 2014 Nov; 46(11):1025-30. PubMed ID: 25190435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease.
    Chebib FT; Harmon A; Irazabal Mira MV; Jung YS; Edwards ME; Hogan MC; Kamath PS; Torres VE; Nagorney DM
    J Am Coll Surg; 2016 Jul; 223(1):118-126.e1. PubMed ID: 27016902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.